Trial Profile
A multi-dose proof-of-concept study of PUR-1800 in patients with chronic obstructive pulmonary disease (COPD)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Aug 2017
Price :
$35
*
At a glance
- Drugs PUR 1800 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Proof of concept; Therapeutic Use
- 08 Aug 2017 New trial record